Diets & Weight Loss

Neoplasm

A tumor

Question: In using the neoplasm table, what do you do when there is no code in cancer in situ? When using the neoplasm table in the ICD-9-CM, how would one code cancer in situ of the temporal lobe?

Answer: You'll never find it there. What you're probably looking for is under skin: Ca in situ of temple or similar.

 


Neoplasm Related Products and News

The News-Press

No charges against survivor in Naples police shooting
The News-Press
 

BLOG: Day 1 of ATA begins with review of testing, guidelines at Trainees ...

Healio
According to Nikiforov, the Afirma gene classifier method has up to 90% to 94% sensitivity for detection of AUS/FLUS, follicular neoplasms, lesions suspicious for follicular neoplasm and suspicious for malignancy. Its high negative predictive value ...
 

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ ...

7thSpace Interactive (press release)
An increased risk of posttransplant malignancy has been consistently reported following various solid organ transplants. The malignancies most commonly encountered are non-melanoma skin cancers, carcinomas of lung or breast and posttransplant ...
 

Leading the Fight Against Breast Cancer

AllAfrica.com
Breast cancer, (malignant breast neoplasm), medical experts say, is cancer originating from breast tissue, most commonly from the inner lining of milk ducts or lobules that supply the ducts with milk. WHO 2013 Report on Global Health Estimates stated ...
 

Proteins associated with pancreatic cancer survival in patients with ...

Nature.com
The corresponding H&E slides were examined under the microscope to delineate the areas with the highest neoplastic cellularity (including both PDAC epithelium and associated stroma), while excluding obvious areas of non-neoplastic pancreatic acinar ...
 

My Kitchen Rules v Media Watch

Crikey
Jane Quin writes: Re. ?The ABC debate: we have Mamamia and BuzzFeed, we don't need the ABC anymore? (Friday). James Paterson argues because we can access news etc globally, we don't need an Australian version that is funded by taxes and not ...
 

Advanced histology in diminutive adenomas three-fold higher in CRC vs ...

Healio
?Whether colorectal cancer patients have high rates of synchronous small advanced neoplasia is unknown but we do know that noninvasive methods of colorectal neoplasm detection such as capsule colonoscopy have been considered for surveillance of ...
 

Stemline Therapeutics Initiates SL-401 Trial In AML Patients In First Complete ...

Benzinga
This trial follows the first trial of SL-401, which is in blastic plasmacytoid dendritic cell neoplasm (BPDCN) and relapsed/refractory AML and is actively accruing patients. Eric K. Rowinsky, M.D., Stemline's Chief Medical Officer and Head of Research ...
 

NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton ...

MarketWatch
Dr. Maher Albitar, the Company's Chief Medical Officer and Director of Research and Development, commented, "Targeting BTK represents a revolutionary approach in the treatment of B-cell neoplasm. We are providing the appropriate means to optimize the ...
 

Clinical Oncology News

Second Cancer: For Many, It's the Price of Survival
Clinical Oncology News